image_1_Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3+CD4+ T Cells.PDF
Two cytokines, fms-related tyrosine kinase 3 ligand (Flt3-L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are considered to be the essential regulators of dendritic cell (DC) development in vivo. However, the combined effect of Flt3-L and GM-CSF on human DCs has not been evaluated in vivo. In this study, we, therefore, aimed at evaluating this using a humanized mouse model. Humanized non-obese diabetic/SCID/Jak3null (hNOJ) mice were constructed by transplanting hematopoietic stem cells from human umbilical cord blood into newborn NOJ mice, and in vivo transfection (IVT) was performed by hydrodynamic injection-mediated gene delivery using plasmids encoding human Flt3-L and GM-CSF. Following IVT, Flt3-L and GM-CSF were successfully induced in hNOJ mice. At 10 days post-IVT, we found, in the spleen, that treatment with both Flt3-L and GM-CSF enhanced the reconstitution of two myeloid DC subsets, CD14−CD1c+ conventional DCs (cDCs) and CD14−CD141+ cDCs, in addition to CD14+ monocyte-like cells expressing CD1c and/or CD141. GM-CSF alone had less effect on the reconstitution of these myeloid cell populations. By contrast, none of the cytokine treatments enhanced CD123+ plasmacytoid DC (pDC) reconstitution. Regardless of the reconstitution levels, three cell populations (CD1c+ myeloid cells, CD141+ myeloid cells, and pDCs) could be matured by treatment with cytokines, in terms of upregulation of CD40, CD80, CD86, and CD184/CXCR4 and downregulation of CD195/CCR5. In particular, GM-CSF contributed to upregulation of CD80 in all these cell populations. Interestingly, we further observed that Foxp3+ cells within splenic CD4+ T cells were significantly increased in the presence of GM-CSF. Foxp3+ T cells could be subdivided into two subpopulations, CD45RA−Foxp3hi and CD45RA−Foxp3lo T cells. Whereas CD45RA−Foxp3hi T cells were increased only after treatment with GM-CSF alone, CD45RA−Foxp3lo T cells were increased only after treatment with both Flt3-L and GM-CSF. Treatment with Flt3-L alone had no effect on the number of Foxp3+ T cells. The correlation analysis demonstrated that the development of these Foxp3+ subpopulations was associated with the maturation status of DC(-like) cells. Taken together, this study provides a platform for studying the in vivo effect of Flt3-L and GM-CSF on human DCs and regulatory T cells.
History
References
- https://doi.org//10.1016/S1471-4906(02)02281-0
- https://doi.org//10.1038/32588
- https://doi.org//10.1038/ni.2467
- https://doi.org//10.1111/j.0105-2896.2009.00888.x
- https://doi.org//10.3389/fmicb.2013.00178
- https://doi.org//10.1111/j.0105-2896.2009.00884.x
- https://doi.org//10.2332/allergolint.R-06-139
- https://doi.org//10.1111/imm.12117
- https://doi.org//10.1038/nri3712
- https://doi.org//10.3389/fimmu.2017.01388
- https://doi.org//10.1016/S0167-5699(00)01694-7
- https://doi.org//10.1084/jem.20141441
- https://doi.org//10.1182/blood-2009-02-206318
- https://doi.org//10.1038/cmi.2012.2
- https://doi.org//10.4049/jimmunol.176.4.2053
- https://doi.org//10.1038/nri3311
- https://doi.org//10.1186/s12865-017-0209-9
- https://doi.org//10.1182/blood-2002-09-2755
- https://doi.org//10.1182/blood-2005-02-0516
- https://doi.org//10.4049/jimmunol.1103660
- https://doi.org//10.1126/science.1093933
- https://doi.org//10.3389/fmicb.2013.00298
- https://doi.org//10.1371/journal.pone.0053495
- https://doi.org//10.1016/j.micinf.2015.02.002
- https://doi.org//10.1007/s12185-008-0215-z
- https://doi.org//10.1016/j.immuni.2007.05.001
- https://doi.org//10.1093/infdis/jit319
- https://doi.org//10.4049/jimmunol.1201789
- https://doi.org//10.1182/blood-2010-08-301507
- https://doi.org//10.1038/sj.mt.6300314
- https://doi.org//10.1073/pnas.0912274106
- https://doi.org//10.1128/AAC.45.2.495-501.2001
- https://doi.org//10.1007/978-1-61779-539-8_29
- https://doi.org//10.3389/fimmu.2014.00131
- https://doi.org//10.4049/jimmunol.165.11.6037
- https://doi.org//10.1182/blood-2001-11-0097
- https://doi.org//10.1038/nri1960
- https://doi.org//10.4049/jimmunol.1302391
- https://doi.org//10.1182/blood-2010-02-258558
- https://doi.org//10.1182/blood-2007-02-071613
- https://doi.org//10.1038/ni.1889
- https://doi.org//10.1084/jem.20141442
- https://doi.org//10.1165/ajrcmb.21.5.3785
- https://doi.org//10.1189/jlb.72.3.546
- https://doi.org//10.1016/j.immuni.2009.03.019
- https://doi.org//10.1186/1742-4690-10-121
- https://doi.org//10.1164/ajrccm.161.4.9906080
- https://doi.org//10.3389/fimmu.2017.01419
- https://doi.org//10.1126/science.aag3009
- https://doi.org//10.1371/journal.pone.0157387
- https://doi.org//10.1126/science.aah4573
- https://doi.org//10.1084/jem.20020045
- https://doi.org//10.1038/nprot.2015.092
- https://doi.org//10.1084/jem.185.6.1101
- https://doi.org//10.4049/jimmunol.168.12.6199
- https://doi.org//10.1038/cmi.2012.48
- https://doi.org//10.1016/j.clim.2008.12.001
- https://doi.org//10.1016/j.clim.2011.08.011
- https://doi.org//10.1016/j.immuni.2009.06.006
- https://doi.org//10.1038/emm.2000.34
- https://doi.org//10.1182/blood-2006-03-011353
- https://doi.org//10.1038/sj.cr.7310017
- https://doi.org//10.1155/2016/3605643
- https://doi.org//10.1093/intimm/dxn147
- https://doi.org//10.1002/eji.201040839
- https://doi.org//10.3389/fimmu.2017.01935
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity